ARCHIVES

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

This article is from The Cancer Letter archive.

Vol. 40 No. 04 | January 24, 2014

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990